Attendo AB (SE:ATT)
:ATT
Want to see SE:ATT full AI Analyst Report?
Top Page
Attendo AB
(ATT)
Select Model
Select Model
Rating:65Neutral
Price Target:
kr108.00
â–²(35.51% Upside)
Action:DowngradedDate:02/07/26
The score is driven primarily by mixed financial fundamentals: strong and improving cash flow and sustained profitability are offset by elevated balance-sheet risk from sharply higher leverage in 2025 and recent margin inconsistency. Technicals are supportive due to a strong uptrend, but overbought readings temper the outlook. Valuation appears roughly fair with a modest dividend yield.
Positive Factors
Strong cash generation
Multi-year pattern of positive operating and free cash flow, including a sizable step-up by 2023–2025, provides durable internal funding for operations, capex and working capital. This strengthens the company's ability to service obligations, invest in quality and support strategic initiatives over months.
Negative Factors
Elevated leverage
A materially higher debt load in 2025 and very high debt-to-equity constrain financial flexibility, heighten refinancing and interest-rate sensitivity, and reduce resilience to shocks. Over the next 2–6 months this aggressive capital structure limits options for investment or cushioning margin volatility.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Multi-year pattern of positive operating and free cash flow, including a sizable step-up by 2023–2025, provides durable internal funding for operations, capex and working capital. This strengthens the company's ability to service obligations, invest in quality and support strategic initiatives over months.
Read all positive factors
Attendo AB (ATT) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr16.22B
Dividend Yield1.47%
Average Volume (3M)307.31K
Price to Earnings (P/E)15.0
Beta (1Y)0.52
Revenue Growth2.96%
EPS Growth73.50%
CountrySE
Employees33,000
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.69
Shares Outstanding151,196,120
10 Day Avg. Volume430,436
30 Day Avg. Volume307,315
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)2.24
Price to Sales (P/S)0.64
P/FCF Ratio4.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.62
Revenue Forecast (FY)kr19.20B
Attendo AB Business Overview & Revenue Model
Company Description
Attendo AB (publ) provides financed care services in Sweden, Finland, Norway, and Denmark. The company offers care services for older people in nursing homes and home care. It also provides disabilities care services for people with disabilities, ...
How the Company Makes Money
Attendo AB generates revenue primarily through government funding and private payments for its care services. The company's revenue model is largely dependent on contracts with municipalities and regions, which provide funding for care services ba...
Attendo AB Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
35
Negative
Cash Flow
72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.99B | 18.98B | 17.29B | 14.50B | 12.87B |
| Gross Profit | 3.20B | 8.20B | 5.92B | 1.52B | 1.42B |
| EBITDA | 3.87B | 3.44B | 3.05B | 2.18B | 1.99B |
| Net Income | 813.00M | 450.00M | 376.00M | -45.00M | 56.00M |
Balance Sheet | |||||
| Total Assets | 25.05B | 25.24B | 22.89B | 22.32B | 21.08B |
| Cash, Cash Equivalents and Short-Term Investments | 1.27B | 821.00M | 922.00M | 507.00M | 513.00M |
| Total Debt | 16.44B | 16.74B | 14.75B | 14.80B | 13.88B |
| Total Liabilities | 19.60B | 19.91B | 17.53B | 17.32B | 16.12B |
| Stockholders Equity | 5.45B | 5.33B | 5.36B | 5.00B | 4.93B |
Cash Flow | |||||
| Free Cash Flow | 2.65B | 2.26B | 2.08B | 1.13B | 1.21B |
| Operating Cash Flow | 2.85B | 2.46B | 2.23B | 1.33B | 1.38B |
| Investing Cash Flow | -330.00M | -1.24B | -185.00M | -390.00M | -413.00M |
| Financing Cash Flow | -2.04B | -1.33B | -1.63B | -970.00M | -1.18B |
Attendo AB Technical Analysis
Positive
79.70
Price Trends
102.27
Positive
92.88
Positive
81.39
Positive
Market Momentum
1.96
Negative
58.23
Neutral
60.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ATT, the sentiment is Positive. The current price of 79.7 is below the 20-day moving average (MA) of 103.48, below the 50-day MA of 102.27, and below the 200-day MA of 81.39, indicating a bullish trend. The MACD of 1.96 indicates Negative momentum. The RSI at 58.23 is Neutral, neither overbought nor oversold. The STOCH value of 60.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:ATT.
Attendo AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | kr1.79B | 24.82 | ― | ― | 13.40% | -63.89% | |
65 Neutral | kr16.22B | 15.03 | ― | 1.47% | 2.96% | 73.50% | |
64 Neutral | kr7.67B | 31.86 | 15.16% | ― | 11.30% | -14.49% | |
63 Neutral | kr10.71B | 17.78 | 12.96% | 1.56% | 10.83% | 16.24% | |
61 Neutral | kr1.57B | 143.44 | ― | ― | ― | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | kr2.44B | 10.62 | 7.53% | 2.01% | 2.11% | 92.69% |
* General Sector Average
SE:ATT
Attendo AB
106.10
46.36
77.61%
SE:HUM
Humana AB
47.20
4.19
9.75%
SE:AMBEA
Ambea AB
135.30
27.14
25.09%
SE:MCAP
MedCap AB
516.00
130.50
33.85%
SE:SUS
Surgical Science Sweden AB
36.86
-88.14
-70.51%
SE:CARA
Carasent AB
23.45
0.97
4.31%
Attendo AB Corporate Events
Attendo Delivers Strong Q4, Lifts Profitability and Sets Higher EPS Target for 2028
Feb 5, 2026
Attendo reported a strong fourth quarter of 2025, with lease-adjusted EBITA rising 53 percent to SEK 343 million despite a 2 percent decline in reported net sales to SEK 4.8 billion, reflecting 5 percent underlying growth when excluding ended cont...
Attendo to Present Updated Financial Targets and Strategy at March Capital Markets Day 2026
Feb 5, 2026
Attendo AB has scheduled a digital Capital Markets Day for 17 March 2026, aimed at institutional investors, analysts and financial media, where senior management will present the company’s updated financial targets and outline its strategic ...
Attendo Launches SEK 200 Million Share Buyback to Adjust Capital Structure
Feb 5, 2026
Attendo’s board has resolved to initiate a share buyback programme of up to SEK 200 million under its 2025 AGM mandate, aiming to optimize the company’s capital structure and to secure shares needed for delivery under ongoing incentive...
Attendo Steps Up Share Buybacks, Nears SEK 200m Programme Limit
Jan 27, 2026
Attendo AB has continued to execute its share buyback programme, repurchasing 289,177 shares on Nasdaq Stockholm during the period 19–23 January 2026 for a total of about SEK 24.8 million at an average price of SEK 85.69 per share. The buyba...
Attendo Sets Date for Year-End 2025 Results and Webcast Presentation
Jan 26, 2026
Attendo AB has scheduled the release of its year-end and fourth-quarter 2025 report for 5 February 2025 at 08:00 CET, followed by a webcast presentation at 10:00 CET hosted in English by CEO Martin Tivéus and CFO Mikael Malmgren. Analysts and...
Attendo Joins SBTi and Commits to Science-Based Climate Targets
Jan 13, 2026
Attendo has joined the Science Based Targets initiative and committed to setting science-based climate targets within the next two years, adding both long- and short-term emissions goals to its existing long-term objectives. Building on years of m...
Attendo Continues Nordic Care Group Share Buybacks, Now Holding Over 5.1 Million Own Shares
Jan 7, 2026
Attendo AB has continued to execute its share repurchase program, buying back 95,089 shares on Nasdaq Stockholm between 29 December 2025 and 2 January 2026 for a total of about SEK 7.8 million at a weighted average price of SEK 81.53. These transa...
Attendo Expands Share Buyback, Lifts Treasury Holdings Past 5 Million Shares
Dec 30, 2025
Attendo AB continued to execute its share repurchase program in week 52 of 2025, buying back 68,303 shares on Nasdaq Stockholm between 22 and 23 December for a total of about SEK 5.6 million at an average price of SEK 81.58 per share. The transact...
Attendo Steps Up Share Buybacks, Now Holds Over 5 Million Own Shares
Dec 23, 2025
Attendo AB has continued to execute its ongoing share buyback programme, repurchasing 130,828 shares on Nasdaq Stockholm during the week of 15–19 December 2025 for a total of about SEK 10.5 million at an average price of SEK 80.13 per share....
Attendo AB Executes Share Repurchase as Part of Strategic Program
Dec 16, 2025
Attendo AB announced the repurchase of 126,005 of its own shares as part of a SEK 200 million repurchase program initiated by the Board. This move, executed on Nasdaq Stockholm, is part of a broader strategy to enhance shareholder value and is con...
Attendo AB Advances Share Repurchase Program
Dec 9, 2025
Attendo AB has repurchased 195,218 of its own shares between December 1 and December 5, 2025, as part of a SEK 200 million repurchase program announced in October 2025. This initiative, conducted under EU regulations, aims to optimize the company&...
Attendo AB Executes Share Repurchase Program
Nov 25, 2025
Attendo AB has repurchased 205,241 of its own shares as part of a SEK 200 million repurchase program initiated by the Board. The program, conducted under EU regulations, aims to strengthen the company’s financial position and market presence...
Attendo AB Advances Share Repurchase Program
Nov 18, 2025
Attendo AB has repurchased a total of 179,641 shares as part of its SEK 200 million share repurchase program, which is in compliance with EU regulations. This initiative, executed by Skandinaviska Enskilda Banken AB on Nasdaq Stockholm, reflects A...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.